CARET
CARET
批准号:
2105674
负责人:
GARY E GOODMAN
金额:
$182.24万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 1999-02-28
关键词:
all trans retinol asbestos blood chemistry cancer prevention cancer risk carotene chemoprevention clinical trials cooperative study drug screening /evaluation environment related neoplasm /cancer female human mortality human subject human therapy evaluation lung neoplasms male mesothelioma nutrition aspect of cancer nutrition related tag occupational hazard prognosis spirometry tobacco abuse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CARET is an ongoing double-blind lung cancer chemoprevention trial of the
efficacy and safety of tide combination of 30 mg beta-carotene and 25,000
IU retinyl palmitate daily in two high-risk populations: (a) male and
female current and former smokers recruited primarily from insurance-based
sources, and (b)males with extensive occupational asbestos exposure
recruited primarily from employment-based sources. We have documented
successful recruitment, excellent adherence, and minimal side effects in
over 15,000 participants randomized thus fur at six study centers. Through
30 April, 1993, CARET has randomized 4,000 asbestos-exposed workers,
exceeding accrual goals at all five CARET asbestos centers, and 11,105
heavy smokers. Seattle and Portland have exceeded their heavy smoker
goals, and Irvine is on track to achieve its goal in July 1994. During the
final five-year period, CARET will focus on retention, adherence to
protocol, ascertainment of endpoints, monitoring of key design parameters,
closeout of the trial, and analysis and publication. Projections indicate
that with 14,240 smokers and 4,010 asbestos-exposed participants and
114,100 person-years of follow-up through February 1998, CARET will be
capable of detecting a. 23% reduction in lung cancer incidence in the two
high-risk populations combined, and 27%, 49%, 32%, and 35% reductions in
the smokers, female smokers, male smokers, and asbestos-exposed subgroups,
respectively.
The Seattle Study Center has a unique responsibility for following the
participants in the original smoker and asbestos-exposed worker pilot
studies, as well as Seattle's share of the CARET Efficacy cohort. Of the
1,845 Pilot participants recruited during 1985-1988, 1,524 (the Vanguard
cohort) continued active participation. These Vanguard participants are
monitored closely to evaluate toxicity potentially related to the
cumulative dose of the study vitamins. The Seattle' Study Center has
surpassed its CARET Efficacy recruitment goals of smokers and asbestos-
exposed workers, in part due to our recently approved access to recruit
members of the American Association of Retired Persons. The Study Center
will continue to emphasize the retention of participants and adherence to
the CARET protocol. The collection of endpoints, which will be increasing
during the final four years, has also become more prominent as recruitment
activities cease. Our data and processing unit will focus on timely
submission and reconciliation of data with the Coordinating Center. As the
largest study center of CARET, we will play a prominent role in analysis
and publication of CARET results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
-
批准号:8790837
-
项目类别:
-
资助金额:$162.56万
-
财政年份:2014
-
负责人:GARY E GOODMAN
-
依托单位:
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
-
批准号:8902092
-
项目类别:
-
资助金额:$132.56万
-
财政年份:2014
-
负责人:GARY E GOODMAN
-
依托单位:
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
-
批准号:8436611
-
项目类别:
-
资助金额:$61.07万
-
财政年份:2013
-
负责人:GARY E GOODMAN
-
依托单位:
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
-
批准号:8637940
-
项目类别:
-
资助金额:$56.02万
-
财政年份:2013
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:7014213
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:7290546
-
项目类别:
-
资助金额:$43.93万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
CARET--COORDINATING CENTER
-
批准号:2376928
-
项目类别:
-
资助金额:$506.7万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL
-
批准号:2855261
-
项目类别:
-
资助金额:$292.7万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6512905
-
项目类别:
-
资助金额:$262.52万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6376060
-
项目类别:
-
资助金额:$254.76万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6893166
-
项目类别:
-
资助金额:$66.8万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
CARET: THE SEATTLE STUDY CENTER
-
批准号:2105676
-
项目类别:
-
资助金额:$184.0万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:7118815
-
项目类别:
-
资助金额:$17.21万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
CARET--COORDINATING CENTER
-
批准号:2667979
-
项目类别:
-
资助金额:$400.83万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6608290
-
项目类别:
-
资助金额:$13.27万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
CARET: THE SEATTLE STUDY CENTER
-
批准号:2105675
-
项目类别:
-
资助金额:$179.58万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6172158
-
项目类别:
-
资助金额:$266.97万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
CARET-Chlamydia pneumonia and risk of lung cancer
-
批准号:6327420
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6502314
-
项目类别:
-
资助金额:$26.84万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
-
批准号:6615575
-
项目类别:
-
资助金额:$219.27万
-
财政年份:1994
-
负责人:GARY E GOODMAN
-
依托单位:
海外基金